3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Completed
2
Recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Stomach Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
3
Esophageal Squamous Cell Carcinoma
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Recurrence
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Advanced Gastric Cancer
2
Thoracic Neoplasms
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Osteosarcoma
1
Neoplasms by Site
1
Mouth Neoplasms
1
Lung Neoplasms
1
Lung Diseases
1
Liver Diseases
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Gestational Trophoblastic Disease
1
Gastrointestinal Neoplasms
1
Interventions
Gemcitabine
39
Cisplatin
24
Oxaliplatin
15
pembrolizumab
12
Capecitabine
12
Fluorouracil
9
Leucovorin
7
Albumin-Bound Paclitaxel
7
lenvatinib
6
Radiofrequency Ablation
6
Panitumumab
6
130-nm albumin-bound paclitaxel
6
Irinotecan
5
Bevacizumab
5
durvalumab
4
Taxes
4
Nivolumab
4
Hepatectomy
4
Drug Therapy
4
tremelimumab
3
apatinib
3
Radiosurgery
3
Platinum
3
Injections
3
Floxuridine
3
Cetuximab
3
1,2-diaminocyclohexaneplatinum II citrate
3
trametinib
2
spartalizumab
2
sintilimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Cholangiocarcinoma
×
camrelizumab
×
Clear all
NCT05236699
2025-02-14
CCGLC-005
Tongji Hospital
Phase 2
Completed
23 enrolled
NCT04642664
2021-06-03
ACABC
Peking Union Medical College Hospital
Phase 2
Completed
22 enrolled